CIB1 Activators are a diverse group of chemical compounds that indirectly stimulate CIB1's functional activity through a variety of specific cellular pathways. For instance, Thapsigargin, a SERCA pump inhibitor, disrupts calcium homeostasis, which is a crucial factor for the calcium-dependent signaling pathways where CIB1 is a key player. By increasing cytosolic calcium levels, Thapsigargin enhances CIB1's role in cell adhesion and motility. Similarly, the calmodulin antagonist W-7 can indirectly boost CIB1's activity by lessening the competition for calcium binding, thereby allowing CIB1 to more effectively participate in calcium-mediated signaling crucial for cell migration and apoptosis. Forskolin, by raising intracellular cAMP, activates PKA, which can then phosphorylate substrates that interact with CIB1, thereby augmenting CIB1's involvement in integrin-mediated cell signaling. Concurrently, PMA, through PKC activation, and Ionomycin, by enhancing intracellular calcium levels, both contribute to the amplification of CIB1's involvement in cytoskeletal organization and cell motility.
The facilitation of CIB1's signaling pathways is further achieved by compounds that modulate secondary messenger systems, with Dibutyryl-cAMP activating PKA, and subsequently, enhancing CIB1's role in platelet function and cell adhesion. Staurosporine, although a broad-spectrum kinase inhibitor, can indirectly heighten CIB1's functions by diminishing the inhibitory effects of certain PKC isoforms on CIB1. Y-27632's inhibition of ROCK leads to an indirect enhancement of CIB1's role in integrin signaling and cell migration. Lastly, BAPTA-AM, through its calcium chelation, fine-tunes calcium signaling and, as such, can indirectly enhance CIB1's activity in calcium-sensitive pathways. Collectively, these CIB1 Activators, by targeting different aspects of cellular signaling, facilitate the enhancement of the functional activities mediated by CIB1.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that disrupts calcium homeostasis within the cell. By increasing cytosolic calcium levels, it can activate calcium-dependent proteins, including those that interact with CIB1, enhancing the CIB1-mediated calcium signaling pathway which is crucial for its role in the regulation of cell adhesion and motility. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels, which in turn activates PKA. PKA can phosphorylate proteins that interact with CIB1, indirectly enhancing CIB1's functional role in processes like integrin-mediated signaling, which is important for cell adhesion and migration. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can modulate various signaling cascades. Activation of PKC has been known to influence the integrin signaling pathway, where CIB1 acts as a modulator. Through PKC activation, PMA can enhance CIB1-mediated downstream effects on cell adhesion and spreading. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, potentiating calcium-dependent signaling pathways. Enhanced calcium signaling can activate proteins that interact with CIB1, leading to the amplification of CIB1's role in modulating cytoskeletal organization and cell motility. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA. By stimulating PKA, db-cAMP can promote CIB1's interaction with other proteins involved in cell adhesion and platelet function, thus enhancing the CIB1-dependent signaling pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent protein kinase inhibitor with the ability to modulate PKC activity. Inhibition of specific PKC isoforms may reduce negative regulatory effects on CIB1, thereby indirectly enhancing CIB1's role in integrin-mediated cell adhesion and intracellular signaling cascades. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that affects cytoskeletal dynamics through the RhoA/ROCK pathway. By inhibiting ROCK, Y-27632 could enhance CIB1's involvement in integrin signaling and cell migration, as CIB1 is known to interact with the cytoskeleton and play a role in these processes. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB modulates store-operated calcium entry (SOCE), which is critical for maintaining calcium signaling. By influencing SOCE, 2-APB can indirectly affect CIB1-related calcium signaling pathways, potentially enhancing CIB1's role in cellular functions such as apoptosis and cell adhesion. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of CaMKII, a calcium/calmodulin-dependent protein kinase. Inhibition of CaMKII may shift the balance of calcium signaling towards CIB1, enhancing its function in processes like endothelial cell barrier function and integrin-mediated signal transduction. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator. By buffering intracellular calcium, BAPTA-AM can fine-tune calcium signaling and therefore indirectly enhance the role of CIB1 in pathways that are sensitive to changes in calcium levels. | ||||||